Q4 2017 INSYS Therapeutics Inc Earnings Call
Llamada en conferencia INSYS Therapeutics Inc
INSYS Therapeutics Inc Conference call or earnings call will be held on 08-mar-2018 via an 800 number (toll-free). During the earnings conference call's session INSYS Therapeutics Inc will provide updated information and financial status.
Conference call is also referred to as: teleconference call or audio conference bridge. Conferencing service is provided in house or as cloud based teleconference service.
In order to join the audio conferencing dial conference bridge and key in the PIN code, Contact INSYS Therapeutics Inc for this information
Schedule a teleconference with QCONF and get 5 free calls with our conference service.
We are a commercial-stage specialty pharmaceutical company that develops and commercializes innovative supportive care products. We have one marketed product: Subsys, a proprietary sublingual fentanyl spray for BTCP in opioid-tolerant adult patients. Insys Therapeutics was incorporated in Delaware in June 1990, and maintains headquarters in Chandler, Arizona. Our parent, Insys Therapeutics, was formerly named Neopharm, Inc. Our subsidiary, Insys Pharma, was formerly called Insys Therapeutics, Inc. On November 8, 2010, Insys Pharma effected a merger with NeoPharm in a transaction accounted for as a reverse acquisition, or the NeoPharm merger. All of our outstanding share capital was exchanged for newly-issued shares of common stock and convertible preferred stock of NeoPharm. As a result of the NeoPharm merger, Insys Pharma became a wholly-owned subsidiary of NeoPharm and changed its name from Insys Therapeutics to Insys Pharma.Leer más Llamada en conferencia